The role of Bruton's tyrosine kinase in B-cell development and function: A genetic perspective

Immunological Reviews

Volumn 175, Issue , 2000, Pages 120-127

  Satterthwaite, Anne B ^a   Witte, Owen N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BIOCHEMISTRY; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; ENZYME REGULATION; GENE MUTATION; GENETIC REGULATION; HUMAN; IMMUNE DEFICIENCY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; MICE; MICE, KNOCKOUT; MUTATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSGENES; X CHROMOSOME;

EID: 0033945186     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.017504.x     Document Type: Article

References (95)

1. 1. Rawlings DJ, et al. Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993;261:358-361.
2. 2. Vetrie D, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993;361:226-233.
3. 3. Tsukada S, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;71:279-290.
4. 4. Thomas JD, Sideras P, Smith CIE, Vorechovsky I, Chapman V, Paul WE. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993;261:355-358.
5. 5. Hardy RR, Hayakawa K, Parks DR, Herzenberg LA. Demonstration of B cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence. Nature 1983;306:270-272.
6. 6. Conley ME. B cells in patients with X-linked agammaglobulinemia. J Immunol 1985;134:3070-3074.
7. 7. Hayakawa K, Hardy RR, Herzenberg LA. Peritoneal Lγ-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol 1986;16:450-456.
8. 8. Sieckmann DG, Asofsky R, Mosier DE, Zitron IM, Paul WE. Activation of mouse lymphocytes by anti-immunoglobulin. J Exp Medicine 1978;147:814-829.
9. 9. Koike M, et al. Defect of IL-5-receptor-mediated signaling in B cells of X-linked immunodeficient (xid) mice. Int Immunol 1995;1:21-30.
10. 10. Go NF, et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990;172:1625-1631.
11. 11. Miyake K. Yamashita Y, Hitoshi Y, Takatsu K, Kimoto M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med 1994;180:1217-1224.
12. 12. Santos-Argumedo L, et al. CD38 unresponsiveness of xid B cell implicates Bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int Immunol 1995;7:163-170.
13. 13. Hasbold J, Klaus GG. B cells from CBA/N mice do not proliferate following ligation of CD40. Eur J Immunol 1994;24:152-157.
14. 14. Perlmutter RM, et al. Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med 1979;149:993-998.
15. 15. Scher I, Steinberg AD, Berning AK, Paul WE. X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect. J Exp Med 1975;142:637-650.
16. 16. Mohamed AJ, Nore BF, Christensson B, Smith CI. Signalling of Bruton's tyrosine kinase, Btk. Scand J Immunol 1999;49:113-118.
17. 17. Kawakami Y, Kitaura J, Hata D, Yao L, Kawakami T. Functions of Bruton's tyrosine kinase in mast and B cells. J Leukoc Biol 1999;65:286-290.
18. 18. Rawlings DJ. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin Immunol 1999;91:243-253.
19. 19. Kurosaki T. Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol 1999;17:555-592.
20. 20. Satterthwaite AB, Li Z, Witte ON. Btk function in B cell development and response. Semin Immunol 1998;10:309-316.
21. 21. Desiderio S. Role of Btk in B cell development and signaling. Curr Opin Immunol 1997;9:534-540.
22. 22. Kerner JD, et al. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 1995;3:301-312.
23. 23. Hendriks RW, de Bruijn MFTR, Maas A, Dingjan GM, Karis A, Grosveld F. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J 1996;15:4862-4872.
24. 24. Khan WN, et al. Defective B-cell development and function in Btk-deficient mice. Immunity 1995;3:283-299.
25. 25. Forrester LM, Ansell JD, Micklem HS. Development of B lymphocytes in mice heterozygous for the X-linked immunodeficiency (Ixid) mutation. J Exp Med 1987;165:949-958.
26. 26. Cariappa A, Kim TJ, Pillai S. Accelerated emigration of B lymphocytes in the Xid mouse. J Immunol 1999;162:4417-4423.
27. 27. Woodland RT, Schmidt MR, Korsmeyer SJ, Gravel KA. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. J Immunol 1996;156:2143-2154.
28. 28. Solvason N, et al. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J Exp Med 1998;187:1081-1091.
29. 29. Rolink AG, Brocker T, Bluethmann H, Kosco-Vilbois MH, Andersson J, Melchers F. Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity 1999;10:619-628.
30. 30. Lodera F, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 1999;190:75-90.
31. 31. Satterthwaite A, Cheroutre H, Khan WN, Sideras P, Witte ON. Btk dosage determines sensitivity to B cell antigen receptor crosslinking. Proc Natl Acad Sci USA 1997;94:13152-13157.
32. 32. Pinschewer DD, Ochsenbein AF, Satterthwaite AB, Witte ON, Hengartner H, Zinkernagel RM. A Blk transgene restores the antiviral TI-2 antibody responses of xid mice in a dose-dependent fashion. Eur J Immunol 1999;29:2981-2987.
33. 33. Li T, et al. Activation of Bruton's tyrosine kinase (Btk) by a point mutation in its pleckstrin homology (PH) domain. Immunity 1995;2:451-460.
34. 34. Dingjan GM, et al. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E4 1K mutated form of Bruton's tyrosine kinase. EMBO J 1998;17:5309-5320.
35. 35. Maas A, Dingjan GM, Grosveld F, Hendriks RW. Early arrest in B cell development in transgenic mice that express the E4 1K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region. J Immunol 1999;162:6526-6533.
36. 36. Vihinen M, et al. Mutations of the human BTK gene coding for Bruton tyrosine kinase in X-linked agammaglobulinemia. Hum Mutat 1999;13:280-285.
37. 37. Tarakhovsky A. Bar mitzvah for B-1 cells: how will they grow up? J Exp Med 1997;185:981-984.
38. + B cells. Immunol Rev 1994;137:91-118.
39. 39. Stall AM, Wells SM, Lam KP. B-1 cells: unique origins and functions. Semin Immunol 1996;8:45-59.
40. 40. Watanabe N, Nisitani S, Ikuta K, Suzuki M, Chiba T, Honjo T. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J Exp Med 1999;190:461-469.
41. 41. Lam KP, Rajewsky K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J Exp Med 1999;190:471-477.
42. 42. Cong YZ, Rabin E, Wortis HH. Treatment of murine CD5 B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol 1991;3:467-476.
43. ̇ B cell precursor in B-1 cell differentiation. J Exp Med 1998;187:1325-1334.
44. 44. Nonoyama S, et al. Functional analysis of peripheral blood B cells in patients with X linked agammaglobulinemia. J Immunol 1998;161:3925-3929.
45. 45. Klaus GG, Holman M, Johnson-Leger C, Elgueta-Karstegl C, Atkins C. A re evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse. Eur J Immunol 1997;27:2749-2756.
46. 46. Anderson JS, Teutsch M, Dong Z, Wortis HH. An essential role for tyrosine kinase in the regulation of Bruton's B-cell apoptosis. Proc Natl Acad Sci USA 1996;93:10966-10971.
47. 47. Khan WN, et al. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int Immunol 1997;9:395-405.
48. 48. Oka Y, et al. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int Immunol 1996;8:1675-1685.
49. 49. Satterthwaite AB, Lowell CA, Khan WN, Sideras P. Alt FW, Witte ON. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways. J Exp Med 1998;188:833-844.
50. 50. Mond JJ, Schaefer M, Smith J, Finkelman FD. Lyb-5-B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig. J Immunol 1983;131:2107-2109.
51. 51. Cowdery JS, Taurog JD, Steinberg AD. Effect of CBA/N xid on spontaneous production of antibodies to DNA in MRL/1 and NZB backcross mice. Scand J Immunol 1980;12:499-502.
52. 52. Scribner CL, Hansen CT, Klinman DM, Steinberg AD. The interaction of the xid and me genes. J Immunol 1987;138:3611-3617.
53. 53. Takeshita H, Taniuchi I, Kato J, Watanabe T. Abrogation of autoimmune disease in Lyn deficient mice by the mutation of the Btk gene. Int Immunol 1998;10:435-444.
54. 54. Murakami M, Yoshioka H, Shirai T, Tsubata T, Honjo T. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol 1995;7:877-882.
55. 55. Rameh LE, et al. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem 1997;271:22059-22066.
56. 56. Salim K, et al. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J 1999;15:6241-6250.
57. 57. Bolland S, Pearse RN, Kurosaki T, Ravetch JV. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998;8:509-516.
58. 58. Scharenberg AM, et al. Phosphatidylinositol-3,4,5 -trisphosphate (Ptdlns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J 1998;17:1961-1972.
59. 59. Li Z, Wahl MI, Eguinoa A, Stephens LR, Hawkins PT, Witte ON. Phosphatidylinositol 3-kinase-γ activates Bruton's tyrosine kinase in concert with Src family kinases. Proc Natl Acad Sci USA 1997;94:13820-13825.
60. 60. Li T, Rawlings DJ, Park H, Kato RM, Witte ON, Satterthwaite AB. Constitutive membrane association potentiates activation of Bruton's tyrosine kinase. Oncogene 1997;15:1375-1383.
61. 61. Mahajan S, Fargnoli J, Burkhardt AL, Kut SA, Saouaf SJ, Bolen JB. Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol Cell Biol 1995;15:5304-5311.
62. 62. Rawlings DJ, et al. Activation of BTK by a phosphorylation mechanism initiated by Src family kinases. Science 1996;271:822-825.
63. 63. Park H, et al. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 1996;4:515-515.
64. 64. Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J Immunol 1999;162:7088-7094.
65. 2+ mobilization. J Exp Med 1999;186:1897-1910.
66. 66. Buhl AM, Cambier JC. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J Immunol 1999;162:4438-4446.
67. 67. Yamadori T, et al. Bruton's tyrosine kinase activity is negatively regulated by sab, the Btk-SH3 domain-binding protein. Proc Natl Acad Sci USA 1999;96:6341-6346.
68. 68. Yao L, Kawakami Y, Kawakami T. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 1994;91:9175-9179.
69. q-protein α-subunit. Nature 1997;389:296-299.
70. 70. Jiang Y, Ma W, Wan Y, Kozasa T, Hattori S. Huang X-Y. The G protein G-α-12 stimulates Bruton's tyrosine kinase and a ras GAP through a conserved PH/BM domain. Nature 1998;395:808-813.
71. 71. Langhans Rajasekaran SA, Wan Y, Huang X-Y. Activation of Tsk and Btk tyrosine kinases by G protein βγ subunits. Proc Natl Acad Sci USA 1995;92:8601-8605.
72. 72. Tsukada S, Simon M, Witte O, Katz A. Binding of the βγ subunits of heterotrimeric G-proteins to the PH domain of Bruton's tyrosine kinase. Proc Natl Acad Sci USA 1994;91:11256-11260.
73. 73. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J Exp Med 1996;184:31-40.
74. 2+ following B-cell receptor activation. EMBO J 1998;17:1973-1985.
75. 75. Hashimoto S, et al. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood 1999;94:2357-2364.
76. 76. Kawakami Y, et al. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc Natl Acad Sci USA 1997;94:3938-3942.
77. 77. Craxton A, Jiang A, Kurosaki T, Clark EA. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. J Biol Chem 1999;274:30644-30650.
78. 78. Novina CD, et al. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Mol Cell Biol 1999;19:5014-5024.
79. 79. Brorson K, et al. xid affects events leading to B cell cycle entry. J Immunol 1997;159:135-143.
80. 80. Cory GOC, Levering RC, Hinshelwood S, MacCarthy-Morrogh L, Levinsky RJ, Kinnon C. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med 1995;182:611-615.
81. 81. Cory GOC, et al. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J Immunol 1996;157:3791-3795.
82. 82. Guinamard R, Fougereau M, Seckinger P. The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS. Scand J Immunol 1997;45:587-595.
83. 83. Fruman DA, et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 1999;283:393-397.
84. 84. Suzuki H, et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 1999;283:390-392.
85. 85. Leitges M, et al. Immunodeficiency in protein kinase Cβ-deficient mice. Science 1996;273:788-791.
86. 86. Coggeshall KM, Cambier JC. B cell activation. VIII. Membrane immunoglobulins transduce signals via activation of phosphatidylinositol hydrolysis. J Immunol 1984;133:3382-3386.
87. 87. Afar DEH, Park H, Howell BW, Rawlings DJ, Cooper J. Witte ON. Regulation of Btk by Src family tyrosine kinases. Mol Cell Biol 1996;16:3465-3471.
88. 88. Wang J, Koizumi T, Watanabe T. Altered antigen receptor signaling and impaired fas-mediated apoptosis of B cells in Lyn-deficient mice. J Exp Med 1996;184:831-838.
89. 89. Chan VWF, Meng F, Soriano P, DeFranco AL, Lowell CA. Characterization of the B lymphocyte populations in lyn-deficient mice and the role of lyn in signal initiation and down-regulation. Immunity 1997;7:69-81.
90. 90. Hibbs ML, et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 1995;83:301-311.
91. 91. Nishizumi H, et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in (lyn)-deficient mice. Immunity 1995;3:549-560.
92. 92. Kurosaki T, Kurosaki M. Transphosphorylation of Bruton's tyrosine kinase on tyrosine Y551 is critical for B cell antigen receptor function. J Biol Chem 1997;272:15595-15598.
93. 93. Guarnieri DJ, Dodson GS, Simon MA. SRC64 regulates the localization of a Tec-family kinase required for Drosophila ring canal growth. Mol Cell 1998;1:831-840.
94. 94. Roulier EM, Panzer S, Beckendorf SK. The Tec29 tyrosine kinase is required during Drosophila embryogenesis and interacts with Src64 in ring canal development. Mol Cell 1998;1:819-829.
95. 95. Baba K, et al. The Drosophila Bruton's tyrosine kinase (Btk) homolog is required for adult survival and male genital formation. Mol Cell Biol 1999;19:4405-4413.